How do you decide if a full-time CRO is right for a PE-backed company when sales and marketing are misaligned?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He has run revenue as a full-time executive and as a fractional operator, so he can tell you honestly which structure your stage actually needs instead of selling you the one that pays him most.

👉 See Kory White on LinkedIn

The PE-Backed Buying Committee and Budget Dynamics

In a PE-backed company, the buying committee for a CRO hire is not the CEO and board alone - it includes the PE firm’s operating partners, the firm’s internal deal team, and often a portfolio-level head of talent. The PE firm holds veto power over the role’s compensation structure, which typically includes a base salary of $250,000-$350,000, a performance bonus tied to EBITDA or revenue growth, and a carried interest or equity stake aligned with the exit event. The budget for the CRO role is approved as part of the 100-day plan post-acquisition, not as a standalone HR decision, and it competes directly with capital allocation for product development or M&A. The buyer (the PE firm) evaluates the CRO candidate on three criteria: ability to compress the sales cycle by 30-40% within 18 months, experience with channel partnerships that can scale without adding headcount, and a track record of building a single pipeline metric that both sales and marketing can rally behind. Deals for a full-time CRO stall when the PE firm cannot agree on whether the misalignment is a people problem (replace the VP of Sales or VP of Marketing) or a process problem (install a revops layer), because hiring a CRO is more expensive and slower than firing one of the two VPs.

The typical deal size for a PE-backed company in this scenario is $50,000-$500,000 ACV, with a sales cycle of 6-12 months and a buying committee that includes the CFO (from the PE firm), the CEO, and heads of revenue operations from the portfolio company. Budget approval for the CRO role requires a formal investment memo to the PE firm’s investment committee, which demands a clear ROI calculation: the CRO’s total cost (salary, bonus, equity, and recruiting fees) must be offset by a projected increase in net new ARR within 12 months. The buyer evaluates the CRO candidate’s past ability to unify disparate forecasting systems - not just their sales leadership credentials - because the PE firm’s primary concern is that the misalignment is inflating the company’s burn rate by 15-20% through duplicated marketing spend and wasted sales capacity. Deals stall when the candidate cannot articulate a specific plan to reduce the cost of customer acquisition by 25% while maintaining gross retention above 90%, because the PE firm’s exit thesis depends on showing a predictable growth engine to potential acquirers.

Sales-Cycle Implications in a Misaligned PE-Backed Environment

The sales cycle in a PE-backed company with sales and marketing misalignment is a forced motion where the two teams operate as separate fiefdoms with different CRM instances or different definitions of a qualified lead. Marketing typically owns the top-of-funnel through demand generation, but sales refuses to accept those leads because they lack intent data or budget confirmation, so the sales team builds its own pipeline through outbound cold calls and partner referrals that marketing never sees. This creates a pipeline shape where marketing reports 500 leads per month, sales reports 50 opportunities, and the CEO sees a gap of 450 leads that never convert - but the real leak is that sales is ignoring marketing’s leads because marketing’s lead scoring model was built for a different buyer persona than the one that actually closes. The ramp behavior for a new CRO is brutal: they must spend the first 30 days auditing both teams’ definitions of a lead, an opportunity, and a closed-won deal, then force a single taxonomy that the CRM enforces with no exceptions. Forecast behavior becomes the CRO’s first test - the PE firm expects a weekly forecast that reconciles sales’ pipeline with marketing’s pipeline contribution, and if the two numbers differ by more than 10%, the CRO must explain why in the operating review.

The leaks in this pipeline are specific to PE-backed dynamics. First, marketing over-invests in brand awareness campaigns that generate top-of-funnel volume but no sales-accepted leads, because the VP of Marketing is measured on MQL volume and the VP of Sales is measured on closed-won revenue, and no one owns the middle of the funnel. Second, sales under-invests in follow-up on marketing-generated leads because the sales team’s compensation is tied to deals they source themselves, so they ignore inbound leads that require more nurturing. Third, the company’s revops function - if it exists - is understaffed and reports to the CFO, not to a single revenue leader, so no one has the authority to enforce lead handoff SLAs or pipeline hygiene. The motion this situation forces is a 90-day sprint to rebuild the entire lead-to-revenue process, starting with a unified lead scoring model that both teams agree to, then a compensation redesign that rewards sales for closing marketing-sourced deals at the same rate as self-sourced deals. The CRO must also negotiate a new budget allocation with the PE firm: marketing’s spend on events and content must be reduced by 20% and redirected to sales enablement tools that help sales close faster, because the PE firm will not tolerate a 50% marketing budget that generates only 20% of closed revenue.

What a Fractional, Interim, and Full-Time Revenue Leader Looks Like Here

For a PE-backed company with sales and marketing misalignment, a fractional revenue leader is a 60-90 day engagement focused on diagnosing the root cause and implementing a tactical fix - they own the audit, the taxonomy cleanup, and the lead handoff process, but they advise on compensation changes rather than owning them. The fractional leader works 10-20 hours per week, reports to the CEO, and delivers a written report to the PE firm’s operating partners with three options: replace the VP of Sales, replace the VP of Marketing, or hire a full-time CRO. Their operating cadence is weekly 90-minute alignment meetings with both VPs, plus a monthly presentation to the PE firm’s investment committee. The signals to convert a fractional leader to full-time are: the misalignment is resolved within 60 days, but the company still lacks a single revenue forecast; or the fractional leader identifies a deeper structural issue, such as a product-market fit problem that requires a CRO to lead a pivot in go-to-market strategy. If the fractional leader finds that the misalignment is a symptom of a CEO who cannot hold two VPs accountable, then a full-time CRO is the only option, because the fractional leader lacks the authority to fire underperformers.

An interim revenue leader is a 3-6 month placement where the PE firm installs a seasoned operator who has previously turned around a misaligned sales and marketing function in a similar portfolio company. The interim CRO owns the full P&L for revenue, including marketing spend, sales headcount, and customer success - they do not advise; they execute. Their first 30 days are spent firing or reassigning the VP of Sales or VP of Marketing if they cannot align, then hiring a revops leader who reports directly to the interim CRO. Their operating cadence is a daily 15-minute standup with both teams, a weekly forecast review with the CEO, and a bi-weekly review with the PE firm’s operating partners. The signals to convert an interim to full-time are: the interim CRO successfully unifies the pipeline within 90 days and delivers two consecutive quarters of predictable revenue growth; or the PE firm decides to extend the hold period and wants continuity in leadership. The signals to not convert are: the interim CRO resolves the misalignment but the company’s growth rate remains below the PE firm’s target of 20% year-over-year, indicating the problem was not just alignment but market demand; or the interim CRO’s style clashes with the company’s culture, which happens often when a PE-backed firm expects a command-and-control leader but the sales team is used to autonomy.

A full-time CRO is the right choice when the misalignment is a systemic issue that requires a permanent change in how the company defines revenue accountability. The full-time CRO owns the entire revenue organization - sales, marketing, customer success, and revops - and reports directly to the CEO and the PE firm’s board. Their first 90 days follow a specific playbook: days 1-30 are spent auditing the CRM, compensation plans, and pipeline definitions; days 31-60 are spent firing or reassigning any leader who cannot commit to a unified revenue process; days 61-90 are spent building a new compensation plan that ties 30% of each VP’s bonus to a shared revenue target, not individual team metrics. Their operating cadence is a weekly revenue review with the CEO and the PE firm’s operating partner, a monthly board presentation, and a quarterly strategic review with the investment committee. The signals to know the full-time CRO is working: within six months, the company has a single forecast that both sales and marketing trust, and the cost of customer acquisition drops by 20% because marketing spend is no longer wasted on leads sales ignores. The signals to know the full-time CRO is not working: after 12 months, the misalignment persists because the CRO cannot change the underlying compensation structure without board approval, or the PE firm’s hold period is too short (under 3 years) to see the return on the CRO’s investment.

The First 90 Days: A PE-Specific Operating Cadence

The first 90 days for a full-time CRO in a PE-backed company are defined by the firm’s 100-day plan, which is a contractual requirement for the CRO to hit specific milestones. By day 30, the CRO must deliver a Revenue Alignment Audit that quantifies the cost of misalignment: how much marketing spend is wasted on leads sales rejects, how much sales capacity is wasted on self-sourcing leads that marketing could have generated, and the impact on customer acquisition cost. By day 60, the CRO must implement a single lead scoring model that both teams agree to, enforced through the CRM with no manual overrides, and redesign the compensation plans so that 20% of each team’s variable compensation is tied to a shared pipeline metric. By day 90, the CRO must deliver a new forecast that reconciles sales’ pipeline with marketing’s pipeline contribution, and present a revised go-to-market budget to the PE firm that shifts 15% of marketing spend from brand awareness to sales enablement. The operating cadence is a weekly 60-minute Revenue Alignment Review with the CEO, the VP of Sales, and the VP of Marketing, where the CRO reviews the pipeline conversion rate from MQL to SQL to closed-won, and flags any team that is not adhering to the new lead handoff SLAs.

The CRO also owns the relationship with the PE firm’s operating partners, which means a monthly 90-minute call to review the company’s revenue performance against the investment thesis. The CRO must report on three metrics: net new ARR growth rate, cost of customer acquisition, and gross retention rate. If the misalignment is resolved but the growth rate remains below the PE firm’s target of 20% year-over-year, the CRO must present a new go-to-market strategy that includes channel partnerships or a shift to a land-and-expand model. The CRO must also manage the PE firm’s expectation that the misalignment will be fixed within six months, because the firm’s hold period is finite and every quarter of misalignment reduces the exit multiple. The CRO’s first 90 days are a stress test: if they cannot unify the forecast by day 60, the PE firm will likely replace them with an interim leader who has done this before.

Signals to Convert Fractional to Full-Time, or Full-Time to Not

The decision to convert a fractional or interim revenue leader to full-time depends on three specific signals in a PE-backed context. First, if the fractional leader resolves the misalignment within 90 days but the company still lacks a single revenue forecast, that is a signal to hire a full-time CRO because the problem was not just alignment but a lack of accountability. Second, if the fractional leader identifies a deeper structural issue - such as a product-market fit problem that requires a pivot in go-to-market strategy - the PE firm should hire a full-time CRO who can lead that pivot over 12-18 months, because a fractional leader cannot commit to a long-term strategy. Third, if the fractional leader finds that the CEO cannot hold the VP of Sales and VP of Marketing accountable, the PE firm must hire a full-time CRO who reports directly to the board, because the CRO will need the authority to fire underperformers without CEO interference.

The signals to not convert a full-time CRO are equally specific. If the CRO has been in role for 12 months and the misalignment persists because the PE firm’s compensation structure prevents the CRO from redesigning sales and marketing incentives, then the CRO is not the right fit - the problem is the PE firm’s governance, not the CRO’s ability. If the CRO’s cost (salary, bonus, equity) exceeds 15% of the company’s total revenue, the PE firm should replace the CRO with a fractional leader who can maintain alignment at a lower cost, because the CRO’s value is not proportional to their expense. If the CRO cannot build a relationship with the PE firm’s operating partners within six months, the CRO should be replaced with an interim leader who has experience in the PE firm’s specific industry, because the operating partners will not trust a CRO who cannot communicate in the language of EBITDA and exit multiples.

FAQ

What is the single biggest mistake PE firms make when hiring a CRO for a misaligned sales and marketing team? The biggest mistake is hiring a CRO who has only led sales or only led marketing, never both. A PE-backed company needs a CRO who has personally managed a unified revenue organization, because the misalignment is not just about handoffs - it is about a single leader who can enforce a single pipeline definition, a single forecast, and a single compensation plan across both teams. A CRO with only sales experience will blame marketing for poor lead quality, while a CRO with only marketing experience will blame sales for poor follow-up, perpetuating the misalignment.

How long does it take to fix sales and marketing misalignment in a PE-backed company? It takes 90 days to implement the structural fixes - unified lead scoring, compensation redesign, and a single forecast - but it takes 12-18 months to see the full impact on revenue growth and customer acquisition cost. The PE firm should expect a 20% reduction in cost of customer acquisition within six months, and a 15% increase in net new ARR within 12 months, provided the CRO has the authority to fire underperformers. If the misalignment is not resolved within 90 days, the PE firm must replace the CRO with an interim leader who has a proven playbook.

Can a fractional CRO fix sales and marketing misalignment in a PE-backed company? Yes, but only if the misalignment is a tactical coordination gap - for example, different lead definitions or a missing lead handoff SLA. A fractional CRO can fix this in 60-90 days by auditing the CRM, implementing a new lead scoring model, and training both teams on a unified process. However, if the misalignment stems from incompatible compensation plans or a CEO who cannot hold VPs accountable, a fractional CRO lacks the authority to fire underperformers or redesign compensation, so a full-time CRO is required.

What happens if the PE firm hires a full-time CRO but the misalignment persists after 12 months? The PE firm must replace the CRO with an interim leader who has experience in the firm’s specific industry, because the problem is likely not the CRO’s ability but the PE firm’s governance. The PE firm should audit the compensation structure to ensure it aligns with the CRO’s authority, and consider whether the misalignment is actually a product-market fit problem that no CRO can fix. If the misalignment is due to the PE firm’s own operating model - for example, requiring the CRO to report to a CFO who controls the budget - then the PE firm must change its governance before hiring a new CRO.

Sources